Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2025-12-25 @ 1:23 AM
NCT ID: NCT06421493
Eligibility Criteria: Inclusion Criteria: * Age \> 18 years * Singleton pregnancy * Live fetus at 11-13 weeks of gestation * Pregnancies complicated by hypertensive disorders (HDP) and fetal growth restriction (FGR) Women with pregnancies complicated by HDP and a fetus with appropriate weight for gestational age (AGAf) * Women with pregnancies complicated solely by early fetal growth restriction (before 34 weeks) * Women with pregnancies complicated solely by late fetal growth restriction (after 34 weeks) * Women identified as high-risk in first-trimester screening for preeclampsia Women identified as high-risk in first-trimester screening for fetal growth restriction * Low-risk pregnancies in first-trimester screening for preeclampsia and fetal growth restriction, with physiological follow-up visits until delivery (homogeneous control sample) Exclusion Criteria: * Multiple pregnancies * Pregnancies complicated by major fetal abnormalities identified during the 11-13 week gestational assessment * Women who are unconscious or severely ill, women with learning difficulties, and those with severe psychiatric disorders * Age \<18 years * Women who have not provided informed consent for the study * Women with HIV, HBV, HCV infection * Women with a history of leukemia and lymphoma * Women with immunodeficiency * Women who have used corticosteroids or other immunosuppressants in the last 3 months
Sex: FEMALE
Minimum Age: 18 Years
Study: NCT06421493
Study Brief:
Protocol Section: NCT06421493